Wolk et al., 2012 - Google Patents
Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditionsWolk et al., 2012
View HTML- Document ID
- 5049781555418983556
- Author
- Wolk D
- Detre J
- Publication year
- Publication venue
- Current opinion in neurology
External Links
Snippet
ASL MRI is just beginning to be applied more widely to various neurodegenerative conditions. Initial data suggest that this methodology may provide similar information to FDG PET, but with several advantages in the ease of acquisition and expense. Additional …
- 230000000626 neurodegenerative 0 title abstract description 16
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/381—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using electromagnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wolk et al. | Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions | |
| Chao et al. | ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia | |
| Doshi et al. | Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage | |
| Vemuri et al. | Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging | |
| Ding et al. | Pattern of cerebral hyperperfusion in Alzheimer’s disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience | |
| Benedetti et al. | Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI | |
| Verclytte et al. | Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG‐PET in early‐onset Alzheimer's disease | |
| Brickman et al. | Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? | |
| Birdsill et al. | Low cerebral blood flow is associated with lower memory function in metabolic syndrome | |
| Jansen et al. | Cerebral blood flow, blood supply, and cognition in Type 2 Diabetes Mellitus | |
| Scola et al. | A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up | |
| Chen et al. | The relationship between cortical blood flow and sub-cortical white-matter health across the adult age span | |
| Jokinen et al. | Diffusion changes predict cognitive and functional outcome: the LADIS study | |
| Raghavan et al. | Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition | |
| Bozzali et al. | Quantitative MRI to understand Alzheimer's disease pathophysiology | |
| Inglese et al. | MRI in multiple sclerosis: clinical and research update | |
| Ziegelitz et al. | Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus | |
| Inglese et al. | Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing–remitting MS | |
| Liu et al. | Determination of spin compartment in arterial spin labeling MRI | |
| Knight et al. | Magnetic resonance imaging to detect early molecular and cellular changes in Alzheimer's disease | |
| Kabani et al. | Regional magnetization transfer ratio changes in mild cognitive impairment | |
| Granziera et al. | In-vivo magnetic resonance imaging of the structural core of the Papez circuit in humans | |
| Virhammar et al. | Idiopathic normal pressure hydrocephalus: cerebral perfusion measured with pCASL before and repeatedly after CSF removal | |
| Uh et al. | In vivo vascular hallmarks of diffuse leukoaraiosis | |
| Tsang et al. | Relationship between sodium intensity and perfusion deficits in acute ischemic stroke |